The corporal myocyte is a critical determinant of erectile capacity whose functional integrity, in the vast majority of impotent patients, is suf®cient to guarantee its relevance as a therapeutic target. As with numerous other smooth muscle cell types, ion channels are important modulators of corporal smooth muscle toneacontractility. As such, the transmembrane¯ow of ions (ie Ca 2 , K and Cl 7 ) plays an important role in modulating membrane potential and contractile status in individual human corporal smooth muscle cells, while intercellular ion¯ow ensures the functionality of myocyte cellular networks. The integral membrane proteins that selectively regulate many aspects of these critical transmembrane (eg K and Ca 2 channels) and intercellular (eg gap junctions) ionic movements have been identi®ed. To date, the large conductance calcium-sensitive K channel (ie K Ca ), the metabolically regulated K channel (ie K ATP ), and the L-type voltage-dependent Ca 2 channel appear to be the most physiologically relevant nonjunctional ion channels. With respect to intercellular ionicasoluteasecond messenger movement, connexin43-derived gap junction channels are widely recognized as an obligatory component to normal integrative erectile biology. The presence of an intercellular pathway ensures that individual cellular alterations are carefully orchestrated in the rapid and syncytial fashion required for normal erectile function. This report reviews the known details concerning junctional and nonjunctional ion channels in human corporal tissue, and illustrates how one particular application of this knowledge, that is, preclinical studies utilizing low ef®cacy gene therapy (ie low transfection ef®ciency) with the K Ca channel has further con®rmed the physiological relevance and therapeutic potential of gap junctions and ion channels to erectile physiologyadysfunction.
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The importance of the corporal myocyte to erectile function, disease and improved therapy
The corporal myocyte is a major regulator of erectile capacity, and as such, understanding modulation of corporal myocyte contractility provides great opportunities for the improved therapy of impotence. This supposition has been veri®ed by numerous basic and clinical studies, 1 ± 17 which have clearly shown that in the absence of severe vascular disease, and barring traumatic injury, congenital or other structural defects, relaxation of the corporal myocyte is necessary and suf®cient for erection. The histologicalaanatomical correlate of these documented facts is that the majority of impotent men possess adequate corporal smooth muscle integrity to ensure an erectile response if the relaxing stimulus is suf®cient. The documented clinical success of commonly used intracavernous agents in more than 70 ± 80% of patients with erectile dysfunction is testimony to the adequacy of corporal myocyte integrity in many impotent men, 2, 16 and more recent clinical studies indicate that this number may be pushed even higher using more ef®cacious muscle relaxants. 17 While these observations do not diminish the critical contribution of central nervous system (CNS) pathways to modulation of erectile physiologyadysfunction, 18 ± 21 they do provide a cogent scienti®c rationale for further studies of corporal smooth muscle contractility. That is, regardless of the therapeutic target (ie central or peripheral), the endpoint is still the same, namely, improved corporal smooth muscle relaxation.
critical to cellular homeostasis and function in all cells, including myocytes. 22 The distribution and concentration of ions (ie K , Ca 2 and Cl 7 ) across the cell membrane determine the resting membrane potential, and thereby set the boundary conditions for the magnitude and direction of current¯ow through ion selective transmembrane pores. This report will not focus on how these gradients are established and maintained, but rather on their relationship to transcellular ionic movements. More speci®cally, the importance of the passive electrochemical diffusion of ions across the corporal myocyte plasma membrane from the intracellular to the extracellular space, and vice versa, will be discussed with respect to their relevance to both erectile physiology and erectile disease ( Figure 1 ). Figure 1 Summary of the ionic equilibria and regulatory mechanisms that control corporal smooth muscle tone. Panel (A) shows the electrochemical gradients which direct the¯ow of ions into and out of the corporal smooth muscle cell. Panel (B) shows a schematic depiction of some of the primary mechanisms thought to modulate corporal smooth muscle cell tone. To illustrate this important point we have arbitrarily divided the myocyte regulatory mechanisms into three distinct components. Note that K channels signi®cantly impact modulation of smooth muscle tone by virtue of their ability to affect both transmembrane calcium¯ux and intracellular calcium homeostasisalevels. Because of their direct and indirect impact on the factors that govern the degree of smooth muscle contractility, they are an ideal target for modulation of smooth muscle tone. SR: sarcoplasmic reticulum; RyR: ryanodine receptor; SMPP: smooth muscle myosin phosphatase; MLCK: myosin light chain kinase. PKAaCaG: protein kinase AaCaG, etc.; DAG: diacylglycerol; IP 3 : inositol trisphosphate. G s aG q : heterotrimeric G proteins coupled to adenylate cyclase and phospholipase C, respectively. Rho A: monomeric G protein. ?-denotes the fact that this pathway is uncon®rmed in the human tissues used in this proposal. The information summarized in Panel (B) was derived from references 43 ± 61.
Ion channels are a convergence point for modulating myocyte contractility
Despite the overt complexity of the bifurcating signal transduction cascades initiated by the wide range of extant neural and hormonal signals, it is clear that nonjunctional ion channels represent a critical convergence point for modulating human corporal smooth muscle tone. Recent molecular and biophysical studies on both freshly isolated tissue strips and individual myocytes from the corpora are beginning to reveal some of the key characteristics of these important molecular targets, 23 ± 33 as well as their putative physiological roles in modulating erectile capacity. These characteristics are discussed later.
The importance of K channels to the modulation of corporal myocyte contractility K channels are major modulators of membrane potential and contractile force in myocytes, and therefore, they have important therapeutic potential. 34 ± 41 Although genes for numerous K channels (more than 30) have already been identi®ed, this report will focus on only two: (1) the large-conductance calcium sensitive K channel (ie the K Ca or maxi-K channel); and (2) the metabolically-gated K channel (ie K ATP ). Our discussion is limited to these two K channel subtypes because there is an extensive literature documenting modulation of their activityafunction by numerous drugs, neurotransmitters, neuromodulators and hormones, following both receptor-and nonreceptor-mediated cellular activation, 34 ± 72 and furthermore, because our published data documents the presence and relevance of these K channel subtypes in the human corpora.
The maxi-K or K Ca channel By far, the K Ca channel is the best described ion channel in human corporal smooth muscle. As with many other voltage-dependent K channels, the K Ca channel is formed by a multimeric complex comprising both a and b subunits ( Figure 2A ). The asubunit of the K Ca is the product of a single slo gene mapped to human chromosome 10q23.1. 73 The cDNA has been cloned, and is refered to as hSlo. 73 Like other voltage-sensitive K channels, the a or pore forming subunit of the K Ca channel, is a tetrameric assembly of homologous subunits. Of interest, hSlo represents the human homologue of the slowpoke (ie hslo) K channel gene originally cloned from the slowpoke locus of mutant Drosophila melanogaster fruit¯ys (refered to as dSlo). The presence of the a subunit in human corporal tissue is documented. 29 Splice variants of the a subunit of Slo have been detected in other tissues, 74 ± 81 indicating the possibility of transcriptional control of K channel function in the human corpora as well. However, the potential physiological relevance of alternatively spliced hSlo transcripts to erectile physiology and function remains to be determined. Also worthy of note is the fact that the a-subunit of the maxi-K channel forms a functional channel when expressed by itself, although the activity of the a-channel is signi®cantly modulated by the presence of the b-subunit.
In this regard, the b-subunit represents the regulatory component of the maxi-K channel, and is present in a 1X1 stoichiometry with the a subunit ( Figure 2A ). When expressed alone, the b-subunit does not form a functional channel, and as such, the perceived role of the b-subunit, in most tissues, is largely that of modulation of a subunit activitya sensitivity to, eg Ca 2 . 79 ± 89 Published studies document the presence of two distinct b-subunits, the b 1 and b 2 -subunits, 78 respectively; although at least one other b-subunit is likely to exist. The b 1 -subunit transcript is apparently most highly expressed in muscle, with transcript levels varying rather dramatically among other tissues (eg brain, liver, lymphatic tissue) 87 A b 2 -subunit has also recently been cloned from chromaf®n cells and hippocampal neurons, and appears to have a K current inactivating role not seen in muscle cells. In contrast to the a-subunit, there are no documented splice variants of the b-subunit. Preliminary data from our laboratory indicate that the b 1 -subunit is present in human corporal tissue (Day et al, unpublished observations, 2000) .
Consistent with the molecular studies, patch clamp experiments also document the presence of the K Ca channel in both cultured and freshly isolated human corporal smooth muscle cells. Speci®cally, the voltage-dependence and calciumsensitivity of the outward whole cell currents, as well as the measured unitary conductance ( 180 ± 200 pS) are typical of those reported for the maxi-K channel in many cell types. 24, 25, 32 Perhaps more importantly, activation of the maxi-K channel is known to play an important role in the relaxation response to prostaglandin E 1 , the most commonly used intracavernosally injectedaintraurethrally applied therapeutic agent for the treatment of erectile dysfunction. That is, PGE 1 -induced production of cAMP in cultured human corporal myocytes 90 and activation of K Ca currents in cultured and freshly isolated human corporal myocytes occurs over the same range of PGE 1 concentrations that relax isolated corporal tissue strips. 91 At the single channel level, the effects of PGE 1 are rountinely manifested as a 3 ± 5 fold increase in the open probability of the K Ca channel. Consistent with such observations, more recent experiments have also shown that the relaxation responses of human corporal tissue strips to PGE 1 , as well as nitroglycerine (NTG) are signi®cantly attenuated by selective blockade of the K Ca channel with 1 mM TEA (Christ, Spektor and Rodriquez, 1999, unpublished observations). Taken together, such observations provide compelling evidence for the mechanistic importance of the K Ca channel to relaxation responses produced by physiologicaly relevant stimuli for erection (ie cAMP and cGMP pathways) (see Figures 1 and 3) .
The K ATP channel
The K ATP channel is a also an octameric complex of a-and b-subunits. The pore forming region is composed of a tetrameric assembly of inward recti®er K channel subunits (ie Kir; the a-subunit) that exist in a 1X1 stoichiometry with a sulfonylurea receptor subunit (ie SUR, the b-subunit and target of orally active sulfonylurea compounds such as glibenclamide) ( Figure 2B ). 62 ± 72 Unlike the pore forming region of the K Ca channel, the tetrameric Kir assembly is not known to form a functional channel in the absence of the SUR subunit. The Kir gene family has been divided into six subfamilies based on the sequence identity of the cloned channel cDNAs. Major subfamilies of 1.0, 2.0 and 6.0 have been identi®ed. The Kir2x and Kir6x are arguably the most relevant to the K ATP channels found in smooth muscle, and thus far, only Kir6.2 is known to be present in human corporal smooth muscle, and will be further discussed herein. 26, 29 Figure 2 Structural cartoons depicting the subunit composition and arrangement of the K Ca (A), K ATP (B) and gap junction (C) channels known to be present in human corporal smooth muscle cells. More speci®cally, panel (A) shows the tetrameric arrangement characteristic of the two subunits that comprise the maxi-K channel (ie a-and b-subunits). Again, note that although not drawn to scale, it is clear that the b-subunit, the regulatory subunit, is much smaller than the a-subunit. Panel (B) illustrates the tetrameric arrangement characteristic of each of the two subunits (ie Kir (a-subunit) and SUR (b-subunit); see text) that comprise the smooth muscle K ATP channel. In this case, the size of the SUR component (the regulatory subunit, but not necessarily drawn to scale) is greater than that of the Kir subunit. Panel (C) shows the hexameric arrangement characteristic of Cx43-derived gap junction channels. Each individually numbered monomer is referred to as a connexin, in this case, Cx43. The six monomeric connexins form a connexon or hemichannel in one cell, and their union across the extracellular space (see Figure 4) provides partial cytoplasmic continuity between adjacent cells.
At least two SUR genes have been identi®ed, SUR1 and SUR2, respectively. Splice variants of SUR2 provide for SUR2A, SUR2B and SUR2C subtypes. There are currently no data available concerning the disposition of the SUR subunit(s) in human corporal myocytes, but this area is currently under investigation. Notably, the recombination of the Kir6.2 subtype with SUR2B isoforms in vitro yields a K ATP -like channel, with a pharmacological and electrophysiological pro®le consistent with the putative K ATP channel recently reported in freshly isolated human corporal myocytes (ie Kir6.2). 26 Studies on isolated tissue strips have con®rmed the ability of several K channel activators (eg pinacidil, cromakalim, lemakalim and nicorandil) to relax corporal smooth muscle from animals and man, and furthermore, to elicit erections in monkeys and humans when injected intracavernosally. 59, 60 Consistent with these pharmacological observations, patch clamp studies on freshly isolated human corporal myocytes have identi®ed two ATPinhibited, glibenclamide sensitive unitary currents, of 20 and 60 pS, respectively. 26 In addition, a pinacidil-induced, glibenclamide-sensitive whole cell outward current has been demonstrated on both cultured 23 and freshly isolated human corporal myocytes. 26 Our observations indicate that pinacidil increases the open probability of both the 20 and 60 pS channels. These observations clearly indicate that the K ATP channel subtype is an important modulator of human corporal smooth muscle tone. Figure 3 Illustration of some primary membrane receptoraeffector pathways known to modulate human corporal smooth muscle tone. A simpli®ed depiction of the major control mechanisms responsible for corporal smooth muscle contraction (top left) and relaxation (top right). This schematic depicts the mechanistic basis for the integral role(s), both direct and indirect, played by K channels (top panels, left and right) and gap junctions (bottom panel) in the modulation of contraction and relaxation responses in myocytes. As shown, the responses of the individual smooth muscle cells, as depicted here and in Figure 1 , must be integrated into syncytial corporal smooth muscle response. The normal functioning of the corporal myocyte cellular networks are critical to ensure the rapid and coordinated contraction and relaxation responses that are a prerequisite to normal erectile function.
Intercellular communication through gap junctions
Gap junctions represent yet another ion channel gene family found in human corporal smooth muscle. In contrast to the tetrameric nature of K channels, the pore forming subunit of gap junctions, refered to as a connexon or hemichannel, are formed by hexamers of connexins ( Figure 2C ). 92 ± 95 The union across the extracellular space of adjacent hemi-channels from cell pairs provide the aqueous intercellular pathway for cytosolic solute diffusion (Figure 4) . Rafts of hundreds to thousands of these individual intercellular channels form the structural basis for the gap junctional plaques reported in human corporal smooth muscle. 96 While more than 12 mammalian connexins have been identi®ed, the diversity of gap junction channels pales in comparison to the diversity of K channels. Gap junctions are named according to their predicted molecular weights, which are known to range from 26 to 56 kD. 92 ± 96 There are no known splice variants of the connexin proteins, and furthermore, there are no reported regulatory subunits associated with the connexin proteins. Finally, a single connexin transcript, that is, connexin43 (ie Cx43) seems to account for the vast majority of intercellular communication in the human corpora. 96 ± 101 The distribution, regulation and biophysical characteristics of Cx43-derived gap junction channels in human corporal smooth muscle are ideally consituted for their required role in coordinating contraction and relaxation responses among the corporal myocytes. Speci®cally, they have a relatively large conductance ( 100 ± 120 pS), a relatively long mean open time (0.5 ± 5 s), a much shorter mean closed time, and therefore, a correspondingly high open probability of 90%. 98 ± 100 Moreover, gap junctions are relatively nonselective ion channels, that is, in contrast to K channels, gap junctions discriminate poorly based on charge as re¯ected by an 0.5 ± 0.8 anionacation selectivity ratio. 94 Gap junctions are permeable to most substances with molecular weights less than 1 kD. In short then, they are ubiquitously distributed, much more likely to be open than closed, and freely permeable to virtually all of the major modulators of corporal smooth muscle tone. It is clear that they are idealy suited for their critical role in modulating erectile capacityafunction (Figure 4 ).
The concept of the`Syncytial Tissue Triad'
It is now clear that nonjunctional ion channels regulate the myocyte cellular response, while gap Figure 4 A cartoon of the organization of, and structural basis for, intercellular communication in human corporal smooth muscle. These structures form the anatomic backbone of the intercellular pathways shown in Figure 3 , and therefore, are critical to ensure the proper functioning of the corporal myocyte network.
junction channels coordinate the composite corporal tissue response. However, how these two components are coordinated with the central and peripheral neural control of erection adds yet another layer of complexity. To address this issue, and obtain an even more complete mechanistic understanding of integrative erectile biology, we have developed a conceptual framework refered to as the`Syncytial Tissue Triad', which takes the additional step of incorporating the functionaactivity of the nervous system into erectile physiology ( Figure 5 ). 4, 102 Brie¯y, the`Syncytial Tissue Traid' posits that coordination of corporal smooth muscle tone, and erectile capacity, occurs at the intersection of the dynamic interplay of the following three components: (1)`The signal', which re¯ects the neuronal innervation density, geometry of innervation, ®ring rate, etc. (2)`Signal transduction', the intracellular signal transduction mechanisms, which re¯ect the response of the corporal myocyte to changes in the extracellular hormonal mileu, and (3)`Signal Spread', which re¯ects the absolute importance of intercellular communication through gap junctions, because the corporal smooth muscle cells are electrically inexcitable (ie not capable of regenerative electrical events). Theoretical treatments of the role of gap junctions and the`syncytial tissue triad' in modulating tissue responses and erectile capacity have recently been codi®ed. 103, 104 The contributions of these three distinct components to normal erectile physiology and function corresponds to intuition, but are nicely veri®ed by the preclinical success of Ion Channel Therapy (ie K channel gene therapy) for the treatment of impaired erectile capacity in the male rat.
Low ef®ciency gene transfer' and the restoration of compromised erectile capacity in the aged and STZ-diabetic rat As previously documented for hSlo gene therapy in retired breed rats, 28, 31 incorporation and expression of hSlo cDNA has also been shown to restore the diabetes-related decline in the nerve-stimulated intracavernosal pressure (ICP) response. 105, 106 Presumably, in both instances, low level expression of a human gene with high sequence homology to the rat sequence accounts for the apparent absence of any detectable immune response (Christ et al, unpublished observations). Moreover, as previously described, 28 the mechanistic basis for the ef®cacy of hSlo gene therapy is most probably related to the Figure 5 Schematic depiction of the`Syncytial Tissue Triad'. increased hyperpolarizing ability provided by the over-expression of K channels on a fraction of the rat corporal myocytes. Cx43-derived intercellular communication ensures that the`augmented' hyperpolarizing signals are spread throughout the corpora resulting in`increased' sensitivity of the myocyte to nerve stimulation; note that the increased sensitivity occurs whether or not there are any other myogenic changes. Such observations bode well for the therapeutic possibilities of gene therapy for the treatment of erectile dysfunction, and moreover, provide an important validation of the concept refered to as the`Syncytial Tissue Triad'.
The importance of ion channel modulation of corporal contractility, rather than pharmacological ablation of corporal contractility In summary, it is clear from the published clinical and experimental literature that relatively subtle alterations in the balance between the effects of endogenous vasoactive substances on the corporal smooth muscle cell are involved in the etiology of erectile failure in a majority of impotent men. 1 ± 15 Equally clear from our recently published preclinical studies on the rat model in vivo is that a relatively subtle increase in the hyperpolarizing ability of the corporal myocytes (as evidenced by the fact that RT-PCR was required to detect the presence of a human gene expressed in the rat corporal smooth muscle cell) is suf®cient to restore the erectile capacity that is compromised by both age-and diabetes-related changes in corporal function. 28, 105, 106 This exciting preclinical observation stands in stark contrast to the traditional pharmacological approach to the treatment of erectile dysfunction, which was largely based on the empirical observation that potent vasorelaxants, such as prostaglandin E 1 , can overwhelm the contractile status of the corporal myocyte to induce erections following intracavernous (ie Caverject 1 ) or intraurethral (MUSE) administration. It is now clear that a new age, one of more subtle and selective oral therapy for the treatment of erectile dysfunction has arrived. This fact is re¯ected by the availability of Viagra TM , and further evidenced from the apparent success of other compounds in late stage clinical trials, such as Uprima. However, even these treatments are dependent on the presence of suf®ciently intact receptoraeffectorasecond messenger pathways for the manifestation of their actionsaef®cacy.
With regard to this, and in light of all of the aforementioned discussion, it seems logical that treatments directed to modulation of ion channels, K channels in particular, may have several intrinsic advantages over currently available forms of therapy. First, K channels are primary modulators of corporal myocyte tone (see Figures 1 ± 3) , and as such, can be activated independent of any given receptoraeffectorasecond messenger pathway. However, because K channels represent an important convergence point for the modulation of corporal smooth muscle tone, their activation will produce smooth muscle relaxation regardless of whether they are directly (ie K channel modulators; see later) or indirectly (ie via second messenger pathways and protein kinase phosphorylation of consensus amino acids sites) activated. Second, because 10 6 ± 10 8 ionsasec can¯ow through an open K channel, it is clear that relatively small alterations (ie increases) in their activity will produce a physiologically relevant degree of corporal smooth muscle cell hyperpolarization, and thus, relaxation. Third, because the corporal myocytes are interconnected by a network of small gap junction assemblies, not every cell would have to`experience' an increase in K channel activity in order for signi®cant smooth muscle relaxation to occur. Fourth, because K channels nominally modulate, but do not ablate, corporal smooth muscle contraction, they are not likely to result in priapism. In conclusion then, it seems that K channel gene therapy approaches, alone or in combination with K channel modulating drugs, would provide an attractive therapeutic strategy for the treatment of erectile dysfunction. Open discussion following Dr Christ's presentation Dr Heaton: You presented the story of ion channels that exist in every cell of the body, so what characterizes the speci®city of the channels that we're going to ®nd in the penis that allow you to manipulate those channels? Is there a sentinel characteristic of potassium channels that makes them have a different key for different parts of the body?
Dr Christ: We have also questioned whether there a tissue-speci®c role for the way the channel operates. For example, suppose that in corpus cavernosum, the open probability of the potassium channel is 1a10 of 1% and in every other cell type in the body, it's 10 times that. Then, suppose a K channel modulator given systemically activated this channel and pick a concentration at which you could increase its activity threefold. If you go from 1a10 of 1% to 3a10 of 1%, you may notice a huge difference in the corpora. But in a cell type that already has an open probability of 5 or 10%, at the same concentration of modulator, you won't notice any difference at all. So, one possibility when you discuss tissue-speci®c functions of potassium channels, is that they spend so much time in the closed state in one organ, that any increase in opening is going to affect function of that organ. If you give somebody a pill, they may not have an erection right away; but if they also have sexual stimuli and thus, a more responsive apparatus because the channels are more likely to be open than closed, that extra signal may really ramp up the open probability of the channels. You increase the hyperpolarizing capacity of the tissue and see a much better erection. The second possibility is that there is splice variance and channel isoforms and also other forms of beta subunits. Combinations and variations in the expression of isoforms in different tissues may provide opportunities to develop drugs for speci®c regions of the channel subunit so that they're only activating the channel in certain tissues.
From our own experience using the in vivo rat model, we can ®nd concentrations of`dirty' K ATP and maxi K channel openers that we can inject intravenously into rats without affecting blood pressure but signi®cantly enhance the nerve stimulated intercavernous pressure-response, and we can block it with selective K channel blockers.
Dr Heaton: In a nutshell, the chances of ®nding penile-speci®c isoforms within the domain of K channels is at least as good and maybe better than it is within the domain of phosphodiesterases.
Dr Christ: Correct. Because with Viagra TM , you only see the signal under certain conditions, even though that isoform is distributed throughout the body.
